Rosemary A Kozar Selected Research

Mesenteric Ischemia

9/2011	Glutamine activates peroxisome proliferator-activated receptor-γ in intestinal epithelial cells via 15-S-HETE and 13-OXO-ODE: a novel mechanism.
1/2011	Enteral arginine modulates inhibition of AP-1/c-Jun by SP600125 in the postischemic gut.
11/2005	Hypertonic saline resuscitation after mesenteric ischemia/reperfusion induces ileal apoptosis.
11/2005	Peroxisome proliferator-activated receptor gamma mediates protection against cyclooxygenase-2-induced gut dysfunction in a rodent model of mesenteric ischemia/reperfusion.
12/2004	The immune-enhancing enteral agents arginine and glutamine differentially modulate gut barrier function following mesenteric ischemia/reperfusion.
5/2004	Enteral glutamine but not alanine maintains small bowel barrier function after ischemia/reperfusion injury in rats.
8/2002	Intraischemic hypothermia differentially modulates oxidative stress proteins during mesenteric ischemia/reperfusion.
6/2002	Alpha-melanocyte-stimulating hormone protects against mesenteric ischemia-reperfusion injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rosemary A Kozar Research Topics

Disease

35	Wounds and Injuries (Trauma) 03/2022 - 05/2002
23	Shock 01/2021 - 05/2002
20	Hemorrhagic Shock 11/2021 - 08/2008
15	Inflammation (Inflammations) 01/2020 - 04/2004
11	Lung Injury 01/2021 - 04/2003
11	Ischemia 04/2015 - 07/2002
10	Hemorrhage 11/2021 - 01/2004
8	Mesenteric Ischemia 09/2011 - 06/2002
7	Critical Illness (Critically Ill) 12/2020 - 09/2002
5	Reperfusion Injury 01/2012 - 06/2002
5	Intra-Abdominal Hypertension 08/2007 - 12/2002
4	Multiple Organ Failure (MODS) 01/2021 - 05/2003
4	Pneumonia (Pneumonitis) 01/2020 - 12/2006
4	Hypoxia (Hypoxemia) 01/2013 - 07/2010
4	Traumatic Shock 11/2009 - 12/2002
3	Abdominal Injuries 12/2015 - 05/2003
3	Hypothermia 12/2011 - 08/2002
2	Vascular System Injuries 12/2017 - 08/2007
2	Edema (Dropsy) 01/2011 - 04/2004
2	Brain Injuries (Brain Injury) 09/2009 - 11/2002
2	Infections 09/2008 - 05/2006
2	Rib Fractures (Rib Fracture) 12/2006 - 04/2003
2	Sepsis (Septicemia) 05/2006 - 11/2005
2	Necrosis 05/2006 - 11/2005
1	Acute Kidney Injury (Acute Renal Failure) 07/2022
1	Abdominal Abscess 07/2022
1	Respiratory Tract Infections (Respiratory Tract Infection) 08/2021
1	Venous Thromboembolism 03/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Exsanguination 01/2020
1	Burns 01/2019
1	Ileus 03/2018
1	Acute Liver Failure (Fulminant Hepatic Failure) 11/2017
1	Liver Diseases (Liver Disease) 11/2017
1	Disease Progression 11/2017
1	Death (Near-Death Experience) 03/2014
1	Sarcopenia 09/2013

Drug/Important Bio-Agent (IBA)

12	Syndecan-1 (Syndecan 1)IBA 01/2021 - 01/2011
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2002
7	Glutamine (L-Glutamine)FDA Link 04/2015 - 09/2002
5	Hemostatics (Antihemorrhagics)IBA 03/2022 - 08/2008
5	Ringer's LactateIBA 01/2021 - 06/2011
5	Arginine (L-Arginine)FDA Link 03/2012 - 12/2004
4	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 04/2015 - 11/2005
4	Glucose (Dextrose)FDA LinkGeneric 09/2008 - 07/2002
3	Thrombin FDA Link 03/2021 - 01/2021
3	Messenger RNA (mRNA)IBA 01/2021 - 11/2005
3	Crystalloid SolutionsIBA 01/2019 - 12/2002
3	Lactic Acid (Lactate)FDA LinkGeneric 05/2018 - 01/2004
3	Alanine (L-Alanine)FDA Link 05/2004 - 07/2002
2	Fibrinogen (Factor I)FDA Link 01/2021 - 01/2020
2	Tranexamic Acid (AMCA)FDA Link 01/2021 - 01/2016
2	salicylhydroxamic acid (SHAM)IBA 01/2021 - 08/2002
2	Peroxidase (Myeloperoxidase)IBA 01/2020 - 11/2005
2	Hemoglobins (Hemoglobin)IBA 09/2012 - 04/2004
2	DNA (Deoxyribonucleic Acid)IBA 01/2011 - 11/2005
2	Poloxamer (Poloxamer 407)IBA 01/2010 - 08/2008
2	Transcription Factors (Transcription Factor)IBA 09/2008 - 03/2005
2	SodiumIBA 07/2006 - 09/2002
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 03/2005 - 11/2003
2	Adenosine Triphosphate (ATP)IBA 05/2004 - 09/2002
2	Heme Oxygenase-1IBA 04/2004 - 11/2003
2	NF-kappa B (NF-kB)IBA 11/2003 - 08/2002
2	Oxygen (Dioxygen)IBA 06/2003 - 11/2002
1	Pharmaceutical PreparationsIBA 08/2021
1	Coloring Agents (Dyes)IBA 01/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2020
1	Evans Blue (Blue, Evans)FDA Link 01/2020
1	Antithrombin IIIIBA 01/2020
1	Hematoxylin (Haematoxylon)IBA 01/2020
1	Bicarbonates (Hydrogen Carbonate)IBA 05/2018
1	Acetaminophen (Paracetamol)FDA LinkGeneric 11/2017
1	Syndecan-2IBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Syndecan-4IBA 01/2017
1	Antifibrinolytic Agents (Antifibrinolytics)IBA 01/2016
1	AdiponectinIBA 01/2016
1	ADAM17 ProteinIBA 11/2015
1	Isoflurane FDA LinkGeneric 04/2015
1	U 0126 (UO 126)IBA 01/2013

Therapy/Procedure

37	Resuscitation 01/2021 - 05/2002
10	Laparotomy 07/2022 - 08/2002
7	Therapeutics 03/2022 - 03/2008
5	Mechanical Ventilators (Ventilator) 03/2018 - 04/2003
4	Enteral Nutrition (Feeding, Tube) 12/2020 - 09/2008
3	Thoracotomy 11/2021 - 10/2015
3	Length of Stay 06/2012 - 04/2003
3	Catheters 11/2009 - 06/2003
2	Splenectomy 03/2022 - 12/2017
2	Ligation 08/2021 - 11/2005
2	Parenteral Nutrition 12/2020 - 03/2018
1	Colostomy 07/2022
1	Electrocoagulation (Electrocautery) 03/2022
1	Sutures (Suture) 03/2022
1	Blood Transfusion (Blood Transfusions) 05/2018
1	Artificial Respiration (Mechanical Ventilation) 03/2018
1	Nutrition Therapy (Medical Nutrition Therapy) 05/2015
1	Anesthesia 04/2015
1	Hospice Care (Care, Bereavement) 03/2014
1	Resuscitation Orders (Do Not Resuscitate Orders) 05/2013